Fundraising FoxOrbis Biosciences
Lenexa, US · Delaware corporation
Find your way into Orbis Biosciences
Sign up to see every warm intro you have to Orbis Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orbis Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CB
Cory BerklandFounder
MF
Maria FlynnExecutiveMaria Flynn founded Orbis Biosciences, a pharmaceutical manufacturing technology company that was acquired by Adare Pharmaceuticals. She served as Managing Director at Techstars Kansas City, where she invested in and mentored startups across health tech, biotech, fintech, and deep tech.
Board
BF
Bowman FishbackBoard director
JC
James ClarkeBoard director
Reported raises · per SEC filings
Form D private placements$985K disclosed across 1 round · 2016
▶$985KraisedApr 2017 · 11 investors · Other TechnologyRule 506(b)
▶$985KraisedApr 2017 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James ClarkeDirector
- Maria FlynnExecutive Officer, Director
- Bowman FishbackDirector
- Cory BerklandExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $985K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 11 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.3M |
| Department of Agriculture (USDA) | Phase I | 2014 | $99.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $1.7M |
| U.S. ArmyArmy | Phase II | 2013 | $491.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $287.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $216K |
| U.S. ArmyArmy | Phase I | 2012 | $149.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $253.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $695.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Orbis Biosciences?
- Orbis Biosciences was founded by Cory Berkland.
- How much funding has Orbis Biosciences raised?
- Orbis Biosciences has disclosed $985K raised across 1 round.
- Where is Orbis Biosciences headquartered?
- Orbis Biosciences is headquartered in Lenexa, US.